Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. April 2012 07:00 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Announces Grant of New U.S. Patent Covering Sapacitabine

BERKELEY HEIGHTS, N.J., April 17, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
04. April 2012 09:00 ET | Quelle: Bio Green Med Solution, Inc.

Personalized Medicine and Combination Potential of Cyclacel's Sapacitabine Highlighted at AACR

BERKELEY HEIGHTS, N.J., April 4, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
02. April 2012 14:00 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel's Novel Polo-Like Kinase 1 (Plk1) Inhibitors Highlighted at AACR

BERKELEY HEIGHTS, N.J., April 2, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
29. März 2012 16:01 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results

BERKELEY HEIGHTS, N.J., March 29, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today its financial results and business...
26. März 2012 16:30 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel to Announce Year-End and Fourth Quarter 2011 Financial Results and Multiple Presentations at the Upcoming AACR Conference

BERKELEY HEIGHTS, N.J., March 26, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced upcoming corporate events. Year...
22. März 2012 16:30 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Announces $3.0 Million Financing to Fund Ongoing Litigation Expenses on Certain Intellectual Property

BERKELEY HEIGHTS, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), today announced that the Company entered into a...
13. Februar 2012 07:00 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Provides Update on Clinical Progress With Sapacitabine as Second Line Therapy in Older Patients With Myelodysplastic Syndromes

BERKELEY HEIGHTS, N.J., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), announced today new topline response data from an...
06. Februar 2012 07:00 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel to Present at Upcoming Investor Conferences

BERKELEY HEIGHTS, N.J., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that Spiro Rombotis, President and...
11. Januar 2012 12:15 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Provides Corporate Update at OneMedForum Conference

BERKELEY HEIGHTS, N.J., Jan. 11, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today summarized its 2011 achievements and set forth...
06. Januar 2012 07:00 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel to Present at the 5th Annual OneMedForum in San Francisco

BERKELEY HEIGHTS, N.J., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced that Spiro Rombotis, President and...

Vorherige Seite

Nächste Seite